New @ DNA

Defond North America Adds New Market Development Manager

Bill Romick, VP of Business Development for Defond North America, LLC, announces today that Mike Zemann has joined the company as a Market Development Manager for the Western US. Read more.

Defond North America Sponsors 2008 North American Solar Challenge

The race for more efficient transportation has taken many roads but none more interesting, innovative and competitive than the North American Solar Challenge. Defond North America was a proud sponsor of the 2008 event. (To find out more, click here.)

News:

President and CEO, Eric Vaughn recently announced the purchase of the outstanding shares in DNA Group, Inc., thus consolidating the ownership of DNA and allowing it to reorganize in a way that will allow it to better serve its customers. (For the full Triangle Business Journal article click here.)

DNA Group, Inc. launches 'Power On' campaign:

DNA Group, Inc. has teamed up with Artículon, a local PR and branding firm, to launch the "Power On" Campaign. The two have been working together to produce a powerful message across all forms of media. "Many of our customers know we produce switches to meet their needs. However, they do not know that we design, produce and deliver so much more." says Eric Vaughn, President and CEO. (To see some of the ads produced, click here.)

Announcing ISO 13485 Certification

Announcing ISO 13485 CertificationDNA's manufacturing partner, Defond, recently acquired ISO 13485 in addition to its ISO 9001, ISO 14001, and TS 16949. ISO 13485 specifies requirements for a quality management system to demonstrate the ability to provide medical devices and related services that consistently meet customer and regulatory requirements. The scope of this quality management system includes production, assembly and repair of electronic systems. DNA and Defond are proud to announce this additional certification to its customers.

Announcing FDA Registration:

Defond has received FDA registration as a contract electronics manufacturer of medical devices allowing DNA Group, Inc. to expand its product offering into the medical device market. (For more of our capabilities, click here.)